Stock News•1 day ago
Establishment Labs: Procedure Economics Strengthens The Bull Case
Establishment Labs' Q2 2026 revenue rose 31.7%, with gross margin expanding to 70.6%, after FDA approval and U.S. entry boosted procedure-based sales. U.S.
MarketLens
Is Evolus (EOLS) Finally Turning the Corner on Profitability
4 months ago
SHARE THIS ON:
Exclusive Content for Pro Members
Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.
SHARE THIS ON:
Related Articles
Category
You may also like
Stock News•2 weeks ago
Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a Bet
Evolus (EOLS) could surge 77.7% per the mean analyst price target, after analysts raised earnings estimates with strong agreement, signaling potential upside.
Stock News•1 months ago
e.l.f. Stock Hasn't Given Investors a Lot to Cheer About Lately. Here's Why That Could Change.
e.l.f. Beauty stock has underperformed recently, but upcoming growth catalysts could shift sentiment.
Breaking News
View All →Featured Articles
Top Headlines
Stock News•56 minutes ago
Palantir Technologies Showcases Sovereign AI Wins With NVIDIA, Cisco and FAA
Stock News•1 hour ago
Here's Why Meta Platforms (META) Fell More Than Broader Market
Stock News•1 hour ago
IBM (IBM) Dips More Than Broader Market: What You Should Know
Stock News•1 hour ago
Tesla (TSLA) Falls More Steeply Than Broader Market: What Investors Need to Know
Stock News•1 hour ago